SPOTLIGHT: EU: Pharma innocent until proven guilty

European regulators want everyone to know that their raids on pharma companies earlier this week don't mean the companies targeted are guilty--just under investigation. Incidentally, add Wyeth and Sandoz to the list of companies who got those surprise visits. Report

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.